Chemotherapy sometimes set the stage for drug-resistant leukemia at relapse

Chemotherapy has helped make the most common childhood cancer one of the most curable, but researchers have evidence that the treatment may also prime some patients for relapse. Results published in the journal Blood reported that treatment-induced mutations cause drug resistance in some patients whose acute lymphoblastic leukemia (ALL) returns. “Our study reveals the evolution dynamics of pediatric ALL, which […]

Continue reading »

Chikungunya antibody set to enter clinical trial

A monoclonal antibody against the chikungunya virus developed by researchers at Vanderbilt University Medical Center is the first monoclonal antibody encoded by messenger RNA to enter a clinical trial. Moderna Inc., a biotechnology firm based in Cambridge, Massachusetts, that is focused on developing mRNA-based vaccines and therapeutics, announced the clinical trial earlier this month. The specific antibody against the mosquito-borne […]

Continue reading »

Major data release set for early 2019 as recruitment wraps up for nation’s largest adolescent brain study

Research teams all across the globe are eagerly awaiting a major release of data from the largest study ever attempted on the adolescent brain. FIU is one of 21 sites studying nearly 11,874 participants collectively, including 2,100 twins or triplets. Researchers will follow the children, currently between the ages of 9 and 10, through young adulthood. Recruitment for participants wrapped […]

Continue reading »

Science of racism examined in new set of research articles

White supremacist marches and xenophobic Twitter rants have brought overt racism to the center of public attention in recent months. Even still, subtle, structural, and systemic forms of racism continue to lurk in what is becoming an increasingly racially diverse United States. In a new collection of scholarly articles, psychological scientists describe research on the enduring and often hidden presence […]

Continue reading »

Relaxation response may reduce blood pressure by altering expression of a set of genes

High blood pressure—or hypertension—is a major risk factor for heart attack and stroke that affects as many as 100 million Americans and 1 billion people worldwide. Decades of research have demonstrated that the relaxation response—the physiological and psychological opposite of the well-known fight-or-flight stress response that can be achieved through relaxation techniques like yoga or mediation – can reduce blood […]

Continue reading »